MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : MAJOR PHARMACEUTICALS
ALKERMES PLC

Alkermes plc XNAS: ALKS

Mid-range Performer

29.66 0.06 (0.20%)

2.8M

XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Alkermes PLC is on 13 Jan 2026 for the purpose of Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference See details

Alkermes PLC - ALKS - stock price prediction, stock price target, analyst ratings from 17 analysts

Alkermes PLC has a share price target of US$ 44, revenue growth forecast of -5.3%, and profit growth estimate of -32.6% for FY25, based on top 17 analyst calls.

Alkermes PLC - ALKS - stock price prediction, stock price target, analyst ratings from 17 analysts

Alkermes PLC has a share price target of US$ 44, revenue growth forecast of -5.3%, and profit growth estimate of -32.6% for FY25, based on top 17 analyst calls.

Forecaster Screeners